Phenotype and polyp landscape in serrated polyposis syndrome: A series of 100 patients from genetics clinics

American Journal of Surgical Pathology

Volumn 36, Issue 6, 2012, Pages 876-882

  Rosty, Christophe ^a,b,c   Buchanan, Daniel D ^c   Walsh, Michael D ^b,c   Pearson, Sally Ann ^c   Pavluk, Erika ^c   Walters, Rhiannon J ^c   Clendenning, Mark ^c   Spring, Kevin J ^c   Jenkins, Mark A ^d   Win, Aung K ^d   Hopper, John L ^d   Sweet, Kevin ^e   Frankel, Wendy L ^f   Aronson, Melyssa ^g   Gallinger, Steve ^g,h,i   Goldblatt, Jack ^j,k   Woodall, Sonja ^l   Arnold, Julie ^l   Walker, Neal I ^m   Jass, Jeremy R ⁿ   Parry, Susan ^o   Young, Joanne P ^b,c   more..

^a ROYAL BRISBANE AND WOMEN'S HOSPITAL   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

^e and Sociology   (United States)

^f OHIO STATE UNIVERSITY   (United States)

^g Zane Cohen Centre for Digestive Diseases   (Canada)

^h CANCER CARE ONTARIO   (Canada)

ⁱ MOUNT SINAI HOSPITAL   (United States)

^j UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^k Genetic Services of Western Australia   (Australia)

^l AUCKLAND CITY HOSPITAL   (New Zealand)

^m Envoi Specialist Pathologists   (Australia)

ⁿ ST MARK S HOSPITAL   (United Kingdom)

^o MIDDLEMORE HOSPITAL   (New Zealand)

more..

Author keywords

Colorectal cancer; Colorectal polyps; Serrated polyposis

Indexed keywords

ADENOSINE TRIPHOSPHATASE; B RAF KINASE; BRAF PROTEIN, HUMAN; DNA; DNA BINDING PROTEIN; KRAS PROTEIN, HUMAN; MLH1 PROTEIN, HUMAN; NUCLEAR PROTEIN; ONCOPROTEIN; PMS2 PROTEIN, HUMAN; POLYDEOXYRIBONUCLEOTIDE SYNTHASE; RAS PROTEIN; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TUMOR MARKER;

ADENOMA; ADOLESCENT; ADULT; AGED; ARTICLE; COLON; COLON POLYP; COLON RESECTION; COLORECTAL TUMOR; FEMALE; GENETICS; HUMAN; HYPERPLASIA; MALE; METABOLISM; MIDDLE AGED; MUTATION; NUCLEOTIDE SEQUENCE; PATHOLOGY; PHENOTYPE; SYNDROME;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOMA; ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGED; COLECTOMY; COLON; COLONIC POLYPS; COLORECTAL NEOPLASMS; DNA MUTATIONAL ANALYSIS; DNA REPAIR ENZYMES; DNA, NEOPLASM; DNA-BINDING PROTEINS; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MUTATION; NUCLEAR PROTEINS; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS B-RAF; RAS PROTEINS; SYNDROME; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 84861231170     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e31824e133f     Document Type: Article

References (33)

1. Beach R, Chan AO,Wu TT, et al. BRAF mutations in aberrant crypt foci and hyperplastic polyposis. Am J Pathol. 2005;166:1069-1075. (Pubitemid 40524431)
2. Boparai KS, Dekker E, Polak MM, et al. A serrated colorectal cancer pathway predominates over the classic WNT pathway in patients with hyperplastic polyposis syndrome. Am J Pathol. 2011;178:2700-2707.
3. Boparai KS, Reitsma JB, Lemmens V, et al. Increased colorectal cancer risk in first-degree relatives of patients with hyperplastic polyposis syndrome. Gut. 2010;59:1222-1225.
4. Boparai KS, van den Broek FJ, van Eeden S, et al. Increased polyp detection using narrow band imaging compared with high resolution endoscopy in patients with hyperplastic polyposis syndrome. Endoscopy. 2011;43:676-682.
5. Buchanan DD, Sweet K, Drini M, et al. Risk factors for colorectal cancer in patients with multiple serrated polyps: a cross-sectional case series from genetics clinics. PLoS One. 2010;5:e11636.
6. Buchanan DD, Sweet K, Drini M, et al. Phenotypic diversity in patients with multiple serrated polyps: a genetics clinic study. Int J Colorectal Dis. 2010;25:703-712.
7. Burt RW, Samowits WS. Serrated adenomatous polyposis: a new syndrome? Gastroenterology. 1996;110:950-952. (Pubitemid 26071865)
8. Bussey HJ. Gastrointestinal polyposis. Gut. 1970;11:970-978.
9. Carr NJ, Mahajan H, Tan KL, et al. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma. J Clin Pathol. 2009;62: 516-518.
10. Carvajal-Carmona LG, Howarth KM, Lockett M, et al. Molecular classification and genetic pathways in hyperplastic polyposis syndrome. J Pathol. 2007;212:378-385. (Pubitemid 47099014)
11. Chan TL, Zhao W, Leung SY, et al. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas. Cancer Res. 2003;63:4878-4881. (Pubitemid 37022620)
12. Chow E, Lipton L, Lynch E, et al. Hyperplastic polyposis syndrome: phenotypic presentations and the role of MBD4 and MYH. Gastroenterology. 2006;131:30-39. (Pubitemid 44015745)
13. Jass JR. Gastrointestinal polyposes: clinical, pathological and molecular features. Gastroenterol Clin North Am. 2007;36:927-946, viii.
14. Jass JR, Baker K, Zlobec I, et al. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a "fusion" pathway to colorectal cancer. Histopathology. 2006;49:121-131. (Pubitemid 44079695)
15. Jass JR, Iino H, Ruszkiewicz A, et al. Neoplastic progression occurs through mutator pathways in hyperplastic polyposis of the colorectum. Gut. 2000;47:43-49. (Pubitemid 30430410)
16. Jass JR, Young J, Leggett BA. Hyperplastic polyps and DNA microsatellite unstable cancers of the colorectum. Histopathology. 2000;37:295-301.
17. Kalady MF, Jarrar A, Leach B, et al. Defining phenotypes and cancer risk in hyperplastic polyposis syndrome. Dis Colon Rectum. 2011;54:164-170.
18. Kambara T, Simms LA, Whitehall VL, et al. BRAF mutation is associated with DNA methylation in serrated polyps and cancers of the colorectum. Gut. 2004;53:1137-1144. (Pubitemid 38961968)
19. Kim KM, Lee EJ, Kim YH, et al. KRAS mutations in traditional serrated adenomas from Korea herald an aggressive phenotype. Am J Surg Pathol. 2010;34:667-675.
20. Kim YH, Kakar S, Cun L, et al. Distinct CpG island methylation profiles and BRAF mutation status in serrated and adenomatous colorectal polyps. Int J Cancer. 2008;123:2587-2593.
21. Longacre TA, Fenoglio-Preiser CM. Mixed hyperplastic adenomatous polyps/serrated adenomas. A distinct form of colorectal neoplasia. Am J Surg Pathol. 1990;14:524-537. (Pubitemid 20172523)
22. Newcomb PA, Baron J, Cotterchio M, et al. Colon Cancer Family Registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:2331-2343. (Pubitemid 351196365)
23. O'Brien MJ, Yang S, Mack C, et al. Comparison of microsatellite instability, CpG island methylation phenotype, BRAF and KRAS status in serrated polyps and traditional adenomas indicates separate pathways to distinct colorectal carcinoma end points. Am J Surg Pathol. 2006;30:1491-1501. (Pubitemid 44808785)
24. Rosty C, Parry S, Young JP. Serrated polyposis: an enigmatic model of colorectal cancer predisposition. Pathol Res Int. 2011;2011:157073,13 pages.
25. Sheridan TB, Fenton H, Lewin MR, et al. Sessile serrated adenomas with low-and high-grade dysplasia and early carcinomas: an immunohistochemical study of serrated lesions "caught in the act". Am J Clin Pathol. 2006;126:564-571. (Pubitemid 44498506)
26. Snover DC, Ahnen DJ, Burt RW, et al. Serrated polyps of the colon and rectum and serrated polyposis. In: Bosman FT, Carneiro F, Hruban RH, et al, eds. WHO Classification of Tumours of the Digestive System. Lyon, France: IARC Press; 2010:160-165.
27. Spring K, Zhao Z, Karamatic R, et al. High prevalence of sessile serrated adenomas with BRAF mutations: a prospective study of patients undergoing colonoscopy. Gastroenterology. 2006;131: 1400-1407. (Pubitemid 44708940)
28. Sweet K, Willis J, Zhou XP, et al. Molecular classification of patients with unexplained hamartomatous and hyperplastic polyposis. JAMA. 2005;294:2465-2473. (Pubitemid 41627924)
29. Torlakovic E, Snover DC. Serrated adenomatous polyposis in humans. Gastroenterology. 1996;110:748-755. (Pubitemid 26071842)
30. Walsh MD, Cummings MC, Buchanan DD, et al. Molecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients. Clin Cancer Res. 2008;14:1692-1700. (Pubitemid 351469453)
31. Walsh MD, Rosty C, Buchanan DD, et al. Origin of colorectal cancers in high-risk serrated neoplasia patients. J Gastroenterol Hepatol. 2010;25:A79.
32. Yang S, Farraye FA, Mack C, et al. BRAF and KRAS Mutations in hyperplastic polyps and serrated adenomas of the colorectum: relationship to histology and CpG island methylation status. Am J Surg Pathol. 2004;28:1452-1459. (Pubitemid 39425511)
33. Yeoman A, Young J, Arnold J, et al. Hyperplastic polyposis in the New Zealand population: a condition associated with increased colorectal cancer risk and European ancestry. N Z Med J. 2007;120:U2827.